[go: up one dir, main page]

PE20080938A1 - Derivados sustituidos de pirrol - Google Patents

Derivados sustituidos de pirrol

Info

Publication number
PE20080938A1
PE20080938A1 PE2007000737A PE2007000737A PE20080938A1 PE 20080938 A1 PE20080938 A1 PE 20080938A1 PE 2007000737 A PE2007000737 A PE 2007000737A PE 2007000737 A PE2007000737 A PE 2007000737A PE 20080938 A1 PE20080938 A1 PE 20080938A1
Authority
PE
Peru
Prior art keywords
optionally substituted
methyl
pirrol
cyane
pyrrol
Prior art date
Application number
PE2007000737A
Other languages
English (en)
Inventor
Mitsuhiro Ito
Nobuyuki Matsunaga
Masami Yamada
Takenori Hitaka
Satoshi Yamamoto
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of PE20080938A1 publication Critical patent/PE20080938A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE PIRROL DE FORMULA (I), EN DONDE R1 ES H, CIANO, ALQUILO(C1-C6) OPCIONALMENTE HALOGENADO O UN ALCOXI-CARBONILO(C1-C6) OPCIONALMENTE SUSTITUIDOS; R2 y R4 SON INDEPENDIENTEMENTE H, ALQUILO(C1-C6), ALQUENILO(C1-C6) SUSTITUIDO CON HIDROXI, TIOL OPCIONALMENTE SUSTITUIDO U OXIDADO, CICLOALQUILO(C1-C6), ENTRE OTROS; R3 ES TIAZOLILO, PIRAZOLILO, OXAZOLILO, ENTRE OTROS OPCIONALMENTE SUSTITUIDOS; R5 ES FENILO OPCIONALMENTE SUSTITUIDO QUE TIENE UN CIANO EN LA POSICION 4 O 3. SON SELECCIONADOS: 4-(2,5-DIMETIL-1-{[3-(TRIFLUOROMETIL)-1H-PIRAZOL-5-IL]METIL}-1H-PIRROL-3-IL)BENZONITRILO; 3-(4-CIANOFENIL)-5-METIL-1-{[3-(TRIFLUROMETIL)-1H-PIRAZOL-5-IL-]METIL}-1H-PIRROL-2-CARBONITRILO; ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR DE ANDROGENOS SIENDO UTILES EN EL TRATAMIENTO DE CANCER DE PROSTATA
PE2007000737A 2006-06-13 2007-06-12 Derivados sustituidos de pirrol PE20080938A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006163992 2006-06-13

Publications (1)

Publication Number Publication Date
PE20080938A1 true PE20080938A1 (es) 2008-09-02

Family

ID=38832218

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000737A PE20080938A1 (es) 2006-06-13 2007-06-12 Derivados sustituidos de pirrol

Country Status (4)

Country Link
AR (1) AR061439A1 (es)
PE (1) PE20080938A1 (es)
TW (1) TW200813007A (es)
WO (1) WO2007145349A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2413504T3 (es) 2007-12-21 2013-07-16 Ligand Pharmaceuticals Inc. Moduladores selectivos del receptor de andrógeno (SARM) y usos de los mismos
CN103102325B (zh) * 2013-01-16 2014-11-12 浙江大学宁波理工学院 一种2-溴代甲基-4-羧酸乙酯噻唑的合成方法
BR112021020864A2 (pt) 2019-04-19 2021-12-14 Ligand Pharm Inc Formas cristalinas e métodos de produção de formas cristalinas de um composto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057669A1 (fr) * 2001-12-28 2003-07-17 Takeda Chemical Industries, Ltd. Antagonistes du recepteur androgene

Also Published As

Publication number Publication date
WO2007145349A3 (en) 2008-04-03
AR061439A1 (es) 2008-08-27
WO2007145349A2 (en) 2007-12-21
TW200813007A (en) 2008-03-16

Similar Documents

Publication Publication Date Title
CY1123578T1 (el) Ισοξαζολινες ναφθαλενιου ως παραγοντες καταπολεμησης ασπονδυλων επιβλαβων οργανισμων
PE20091653A1 (es) Derivados sustituidos de pirazol y su uso
PE20081362A1 (es) DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K
PE20061439A1 (es) DERIVADOS DE 2-AMIDO-6-AMINO-8-OXO-PURINA COMO MODULADORES DEL RECEPTOR Toll (TLR)
AR059249A1 (es) Compuesto amina trisustituido
PE20090775A1 (es) Nuevos derivados de biarilo
PE20061084A1 (es) Compuestos derivados de 2-ciano-3-(halo)alcoxi-bencenosulfonamida
PE20080697A1 (es) Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
PE20070427A1 (es) Compuestos derivados de benzimidazoles sustituidos como inhibidores de tirosina quinasas
PE20110875A1 (es) Derivados de isoindol como inhibidores de bace
PE20121282A1 (es) Antagonistas de espiro-oxindol de mdm2
PE20090058A1 (es) Compuestos carboxamida heterociclicos como inhibidores de la actividad akt
PE20141203A1 (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
PE20061303A1 (es) Composicion farmaceutica que comprende oxaprozina
AR071609A1 (es) Inhibidores ciclicos de 11(beta) -hidroxiesteroide deshidrogenasa 1
PE20120008A1 (es) Derivados de fenoxi bencenosulfonamida
AR039563A1 (es) Derivados de 4-(imidazol-5-il)-2-(4-sulfoanilino)pirimidina con actividad inhibidora de cdk
CL2008001668A1 (es) Compuestos derivados de piperidin o piperazin carboxamida; composicion farmaceutica; y su uso en el tratamiento de la obesidad, hipercolesterolemia, dislipidemia, hipertrigliceridemia, higado graso, fibrosis hepatica, hepatitis, entre otras, mediadas por dgat.
PE20091527A1 (es) Derivados de piridazinona
PE20110433A1 (es) Antagonistas de la via hedgehog de ftalazina disustituida
MX2010000658A (es) Derivados de pirimidina 934.
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
PE20061316A1 (es) Derivados de pirazol como antagonistas del receptor de progesterona
CO6160324A2 (es) Heterociclos sustituidos que contienen nitrogeno como inhibidores del receptor adp plaquetario
BRPI0912171A8 (pt) Composto ativador de receptor de glicocorticoide, e, composição

Legal Events

Date Code Title Description
FD Application declared void or lapsed